ArticleCancer immunology, immunotherapy : CII2025

Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.

Silvia Zaninelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.